Nancy Wong

Nancy Wong

UNVERIFIED PROFILE

Are you Nancy Wong?   Register this Author

Register author
Nancy Wong

Nancy Wong

Publications by authors named "Nancy Wong"

Are you Nancy Wong?   Register this Author

47Publications

1275Reads

37Profile Views

Development of an oxirane/acrylate interpenetrating polymer network (IPN) resin system.

Dent Mater 2018 10 1;34(10):1459-1465. Epub 2018 Aug 1.

Department of Comprehensive Dentistry, the University of Texas Health Science Center at San Antonio, San Antonio, TX, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01095641173071
Publisher Site
http://dx.doi.org/10.1016/j.dental.2018.06.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311097PMC
October 2018

Sustained Accumulation of Microtubule-Binding Chemotherapy Drugs in the Peripheral Nervous System: Correlations with Time Course and Neurotoxic Severity.

Cancer Res 2016 06 13;76(11):3332-9. Epub 2016 Apr 13.

Johns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, Maryland. Department of Neurology, Medicine Psychiatry, and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891279PMC
http://dx.doi.org/10.1158/0008-5472.CAN-15-2525DOI Listing
June 2016

CtIP-mediated resection is essential for viability and can operate independently of BRCA1.

J Exp Med 2014 Jun 19;211(6):1027-36. Epub 2014 May 19.

Laboratory of Genome Integrity, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20131939DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042650PMC
June 2014

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the novel γ-secretase modulator, E2212, in healthy human subjects.

J Clin Pharmacol 2014 May 2;54(5):528-36. Epub 2014 Jan 2.

Department of Clinical Pharmacology, Eisai Inc., Woodcliff Lake, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.249DOI Listing
May 2014

Evaluation of AlloMax acellular dermal matrix for objective collagen deposition.

J Reconstr Microsurg 2014 Jan 17;30(1):31-4. Epub 2013 Jul 17.

Department of Surgery, University of Nevada School of Medicine, Las Vegas, Nevada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0033-1349721DOI Listing
January 2014

A transcellular assay to assess the P-gp inhibition in early stage of drug development.

Drug Metab Lett 2012 ;6(4):285-91

Drug Metabolism and Pharmacokinetics, Biopharmaceutical Assessments Core Function Unit, Eisai Inc., USA.

View Article

Download full-text PDF

Source
October 2013

The effect of lipoaspirates cryopreservation on adipose-derived stem cells.

Aesthet Surg J 2013 Sep 21;33(7):1046-55. Epub 2013 Aug 21.

Department of Surgery, Division of Plastic Surgery at the University of Nevada School of Medicine, Las Vegas, Nevada.

View Article

Download full-text PDF

Source
http://asj.oxfordjournals.org/content/asj/33/7/1046.full.pdf
Web Search
http://asj.oxfordjournals.org/cgi/doi/10.1177/1090820X135016
Publisher Site
http://dx.doi.org/10.1177/1090820X13501690DOI Listing
September 2013

Application of a substrate cocktail approach in the assessment of cytochrome P450 induction using cultured human hepatocytes.

J Biomol Screen 2013 Feb 15;18(2):199-210. Epub 2012 Oct 15.

Eisai, Inc., Andover, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1087057112463732DOI Listing
February 2013

Characterization of the pharmacokinetics of a liposomal formulation of eribulin mesylate (E7389) in mice.

Int J Pharm 2013 Feb 11;443(1-2):9-16. Epub 2013 Jan 11.

DMPK, BA-CFU, Eisai Inc., 4 Corporate Drive, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03785173130002
Publisher Site
http://dx.doi.org/10.1016/j.ijpharm.2013.01.010DOI Listing
February 2013

Analysis for apoptosis and necrosis on adipocytes, stromal vascular fraction, and adipose-derived stem cells in human lipoaspirates after liposuction.

Plast Reconstr Surg 2013 Jan;131(1):77e-85e

Department of Surgery, Division of Plastic Surgery, University of Nevada School of Medicine, Las Vegas 89102, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0b013e3182729ff7DOI Listing
January 2013

Safety, pharmacokinetics and pharmacodynamics of four-hour intravenous infusions of eritoran in healthy Japanese and Caucasian men.

Innate Immun 2012 Dec 29;18(6):793-803. Epub 2012 Mar 29.

Emergency and Critical Care Medicine, School of Medicine, Keio University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753425912441845DOI Listing
December 2012

Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.

Cancer Chemother Pharmacol 2012 Jan 23;69(1):229-37. Epub 2011 Jun 23.

Non-clinical Drug Development, Cubist Pharmaceuticals, 65 Hayden Avenue, Lexington, MA 02421, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1687-8DOI Listing
January 2012

Investigation of the metabolism of rufinamide and its interaction with valproate.

Drug Metab Lett 2011 Dec;5(4):280-9

Eisai Inc., Andover, Massachusetts 01810, USA.

View Article

Download full-text PDF

Source
December 2011

Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.

Drug Metab Dispos 2011 Aug 3;39(8):1329-33. Epub 2011 May 3.

BD Biosciences, Bedford, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.111.039628DOI Listing
August 2011

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells.

Xenobiotica 2011 Apr 17;41(4):320-6. Epub 2010 Dec 17.

DMPK-Andover, Biopharmaceutical Assessments, Eisai Inc., Andover, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/00498254.2010.542256DOI Listing
April 2011

A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.

Drug Metab Dispos 2011 Jan 14;39(1):61-70. Epub 2010 Oct 14.

Drug Metabolism and Pharmacokinetics-Andover, Biopharmaceutical Assessments, Eisai Inc., Andover, Massachusetts 01810-2441, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.110.035360DOI Listing
January 2011

Chimeric IgH-TCRalpha/delta translocations in T lymphocytes mediated by RAG.

Cell Cycle 2009 Aug 21;8(15):2408-12. Epub 2009 Aug 21.

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587430PMC
http://dx.doi.org/10.4161/cc.8.15.9085DOI Listing
August 2009

Phase I study of eribulin mesylate administered once every 21 days in patients with advanced solid tumors.

Clin Cancer Res 2009 Jun 9;15(12):4213-9. Epub 2009 Jun 9.

The Cancer Institute of New Jersey, New Brunswick, New Jersey 08901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-0360DOI Listing
June 2009

Continuous pharmacodynamic activity of eritoran tetrasodium, a TLR4 antagonist, during intermittent intravenous infusion into normal volunteers.

Innate Immun 2008 Dec;14(6):383-94

Eisai Medical Research Inc., Ridgefield Park, New Jersey 07660, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753425908099173DOI Listing
December 2008

A high-performance liquid chromatography-tandem mass spectrometry method for the clinical combination study of carboplatin and anti-tumor agent eribulin mesylate (E7389) in human plasma.

J Chromatogr B Analyt Technol Biomed Life Sci 2008 Nov 19;875(2):373-82. Epub 2008 Sep 19.

Drug Safety and Disposition, Eisai Research Institute, 4 Corporate Drive, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S157002320800686
Publisher Site
http://dx.doi.org/10.1016/j.jchromb.2008.09.013DOI Listing
November 2008

53BP1 facilitates long-range DNA end-joining during V(D)J recombination.

Nature 2008 Nov 19;456(7221):529-33. Epub 2008 Oct 19.

Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1360, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature07476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596817PMC
November 2008

Preferential inducibility of CYP1A1 and CYP1A2 by TCDD: differential regulation in primary human hepatocytes versus transformed human cells.

Biochem Biophys Res Commun 2006 Mar 11;341(2):399-407. Epub 2006 Jan 11.

Department of Drug Disposition, Eisai Research Institute, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X0600010
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2005.12.203DOI Listing
March 2006

Enzyme kinetics for clinically relevant CYP inhibition.

Curr Drug Metab 2005 Jun;6(3):241-57

Drug Disposition, Eisai Research Institute, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
June 2005

Extended in vivo pharmacodynamic activity of E5564 in normal volunteers with experimental endotoxemia [corrected].

J Pharmacol Exp Ther 2004 Jan 17;308(1):175-81. Epub 2003 Oct 17.

Eisai Medical Research Inc., Glenpointe Centre West, Teaneck, New Jersey 07666-6741, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.103.056531DOI Listing
January 2004

Pharmacokinetics of E5564, a lipopolysaccharide antagonist, in patients with impaired hepatic function.

J Clin Pharmacol 2003 Dec;43(12):1361-9

Drug Safety and Disposition Department, Eisai Research Institute, 100 Research Drive, Wilmington, MA 01887, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0091270003258653DOI Listing
December 2003

Safety, pharmacokinetics, and pharmacodynamics of E5564, a lipid A antagonist, during an ascending single-dose clinical study.

J Clin Pharmacol 2003 Jul;43(7):735-42

Eisai Research Institute, 1 Corporate Drive, Andover, MA 01810, USA.

View Article

Download full-text PDF

Source
July 2003

In vitro interactions between a potential muscle relaxant E2101 and human cytochromes P450.

Drug Metab Dispos 2002 Jul;30(7):805-13

Department of Drug Safety and Disposition, Eisai Research Institute, Wilmington, Massachusetts 01887, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.30.7.805DOI Listing
July 2002